DRNA
Dicerna Pharmaceuticals Inc
Price:  
38.22 
USD
Volume:  
5,675,030.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DRNA DCF Valuation - Growth Exit 5Y

-476.0%
Upside

What is the DCF valuation of DRNA??

The Discounted Cash Flow (DCF) valuation of Dicerna Pharmaceuticals Inc (DRNA) is (143.72) USD. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on DCF is -476.0%.

Is DRNA a buy or a sell?

Based on the latest price of 38.22 USD and our DCF valuation, Dicerna Pharmaceuticals Inc (DRNA) is a sell. selling DRNA stocks now will result in a potential gain of 476.0%.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
WACC / Discount Rate 5.7% - 7.5% 6.6%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price (535.46) - (83.71) (143.72)
Upside -1501.0% - -319.0% -476.0%
38.22 USD
Stock Price
(143.72) USD
Fair Price